These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Contribution of VanY D,D-carboxypeptidase to glycopeptide resistance in Enterococcus faecalis by hydrolysis of peptidoglycan precursors. Arthur M; Depardieu F; Snaith HA; Reynolds PE; Courvalin P Antimicrob Agents Chemother; 1994 Sep; 38(9):1899-903. PubMed ID: 7810996 [TBL] [Abstract][Full Text] [Related]
24. Heteroresistance to vancomycin and novel point mutations in Tn1546 of Enterococcus faecium ATCC 51559. Khan SA; Sung K; Layton S; Nawaz MS Int J Antimicrob Agents; 2008 Jan; 31(1):27-36. PubMed ID: 17936593 [TBL] [Abstract][Full Text] [Related]
25. Regulation of VanB-type vancomycin resistance gene expression by the VanS(B)-VanR (B) two-component regulatory system in Enterococcus faecalis V583. Evers S; Courvalin P J Bacteriol; 1996 Mar; 178(5):1302-9. PubMed ID: 8631706 [TBL] [Abstract][Full Text] [Related]
26. Purification and characterization of VanXY(C), a D,D-dipeptidase/D,D-carboxypeptidase in vancomycin-resistant Enterococcus gallinarum BM4174. Podmore AH; Reynolds PE Eur J Biochem; 2002 Jun; 269(11):2740-6. PubMed ID: 12047383 [TBL] [Abstract][Full Text] [Related]
27. Requirement of the VanY and VanX D,D-peptidases for glycopeptide resistance in enterococci. Arthur M; Depardieu F; Cabanié L; Reynolds P; Courvalin P Mol Microbiol; 1998 Nov; 30(4):819-30. PubMed ID: 10094630 [TBL] [Abstract][Full Text] [Related]
28. Substrate Inhibition of VanA by d-Alanine Reduces Vancomycin Resistance in a VanX-Dependent Manner. van der Aart LT; Lemmens N; van Wamel WJ; van Wezel GP Antimicrob Agents Chemother; 2016 Aug; 60(8):4930-9. PubMed ID: 27270282 [TBL] [Abstract][Full Text] [Related]
29. Real-time monitoring of D-Ala-D-Ala dipeptidase activity of VanX in living bacteria by isothermal titration calorimetry. Lv M; Zhang YJ; Zhou F; Ge Y; Zhao MH; Liu Y; Yang KW Anal Biochem; 2019 Aug; 578():29-35. PubMed ID: 31071297 [TBL] [Abstract][Full Text] [Related]
30. Emergence of a vancomycin-variable Enterococcus faecium ST1421 strain containing a deletion in vanX. Hansen TA; Pedersen MS; Nielsen LG; Ma CMG; Søes LM; Worning P; Østergaard C; Westh H; Pinholt M; Schønning K J Antimicrob Chemother; 2018 Nov; 73(11):2936-2940. PubMed ID: 30113682 [TBL] [Abstract][Full Text] [Related]
31. New combinations of mutations in VanD-Type vancomycin-resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium strains. Depardieu F; Foucault ML; Bell J; Dubouix A; Guibert M; Lavigne JP; Levast M; Courvalin P Antimicrob Agents Chemother; 2009 May; 53(5):1952-63. PubMed ID: 19258279 [TBL] [Abstract][Full Text] [Related]
32. Identification of a new chromophoric substrate in the library of amino acid p-nitroanilides for continuous assay of VanX, a D,D-dipeptidase essential for vancomycin resistance. Hsieh ML; Tseng MJ; Tseng MC; Chu YH Anal Biochem; 2006 Jul; 354(1):104-10. PubMed ID: 16701071 [TBL] [Abstract][Full Text] [Related]
33. New chromogenic dipeptide substrate for continuous assay of the D-alanyl-D-alanine dipeptidase VanX required for high-level vancomycin resistance. Anissimova M; Yaouancq L; Noor F; Badet-Denisot MA; Badet B J Pept Res; 2003 Aug; 62(2):88-95. PubMed ID: 12823621 [TBL] [Abstract][Full Text] [Related]
34. VanX, a bacterial D-alanyl-D-alanine dipeptidase: resistance, immunity, or survival function? Lessard IA; Walsh CT Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11028-32. PubMed ID: 10500118 [TBL] [Abstract][Full Text] [Related]
35. Effect of Vancomycin on Cytoplasmic Peptidoglycan Intermediates and Gargvanshi S; Vemula H; Gutheil WG J Bacteriol; 2021 Jul; 203(16):e0023021. PubMed ID: 34060906 [TBL] [Abstract][Full Text] [Related]
36. Mechanism-based inactivation of VanX, a D-alanyl-D-alanine dipeptidase necessary for vancomycin resistance. Aráoz R; Anhalt E; René L; Badet-Denisot MA; Courvalin P; Badet B Biochemistry; 2000 Dec; 39(51):15971-9. PubMed ID: 11123924 [TBL] [Abstract][Full Text] [Related]
37. Biochemical and biophysical characterization of an unexpected bacteriolytic activity of VanX, a member of the vancomycin-resistance vanA gene cluster. Sohya S; Kamioka T; Fujita C; Maki T; Ohta Y; Kuroda Y J Biol Chem; 2014 Dec; 289(52):35686-94. PubMed ID: 25294880 [TBL] [Abstract][Full Text] [Related]
38. Transcriptional regulation of the Enterococcus faecium BM4147 vancomycin resistance gene cluster by the VanS-VanR two-component regulatory system in Escherichia coli K-12. Haldimann A; Fisher SL; Daniels LL; Walsh CT; Wanner BL J Bacteriol; 1997 Sep; 179(18):5903-13. PubMed ID: 9294451 [TBL] [Abstract][Full Text] [Related]
39. Mechanisms of glycopeptide resistance in enterococci. Arthur M; Reynolds PE; Depardieu F; Evers S; Dutka-Malen S; Quintiliani R; Courvalin P J Infect; 1996 Jan; 32(1):11-6. PubMed ID: 8852545 [TBL] [Abstract][Full Text] [Related]
40. High prevalence of VanB2 vancomycin-resistant Enterococcus faecium in Taiwan. Lu JJ; Perng CL; Ho MF; Chiueh TS; Lee WH J Clin Microbiol; 2001 Jun; 39(6):2140-5. PubMed ID: 11376048 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]